Tags : BioMedX

Pharma

BioMed X and Boehringer Ingelheim (BI) Collaborates for Neurology Disorders

Shots: BI & BioMed X enters into an agreement to develop strategies for early detection of psychiatric disorders The focus of the agreement is for exploring adolescence’s neurobiology for the prevention & development of the psychiatric pathologies such as schizophrenia In 2014, the companies collaborated and have launched three preclinical researches projects for neurology disorders […]Read More